DOCSLIB.ORG

Human Rabies Prevention — United States, 1999

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Human Rabies Prevention — United States, 1999 January 8, 1999 / Vol. 48 / No. RR-1 TM Recommendations and Reports Human Rabies Prevention — United States, 1999 Recommendations of the Advisory Committee on Immunization Practices (ACIP) Continuing Education Examination Education Continuing Inside: U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Atlanta, Georgia 30333 The MMWR series of publications is published by the Epidemiology Program Office, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Hu- man Services, Atlanta, GA 30333. SUGGESTED CITATION Centers for Disease Control and Prevention. Human rabies prevention — United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-1):[inclusive page numbers]. Centers for Disease Control and Prevention....................Jeffrey P. Koplan, M.D., M.P.H. Director The material in this report was prepared for publication by National Center for Infectious Diseases.................................. James M. Hughes, M.D. Director Division of Viral and Rickettsial Diseases .................. Brian W.J. Mahy, Ph.D., Sc.D. Director The production of this report as an MMWR serial publication was coordinated in Epidemiology Program Office.................................... Stephen B. Thacker, M.D., M.Sc. Director Office of Scientific and Health Communications ......................John W. Ward, M.D. Director Editor, MMWR Series Recommendations and Reports................................... Suzanne M. Hewitt, M.P.A. Managing Editor Valerie R. Johnson Project Editor Morie M. Higgins Visual Information Specialist Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. Copies can be purchased from Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402-9325. Telephone: (202) 512-1800. Vol. 48 / No. RR-1 MMWR i Contents Introduction...........................................................................................................1 Rabies Biologics....................................................................................................2 Vaccines Licensed for Use in the United States..........................................3 Human Diploid Cell Vaccine (HDCV) ......................................................3 Rabies Vaccine Adsorbed (RVA) .............................................................3 Purified Chick Embryo Cell Vaccine (PCEC)...........................................3 Rabies Immune Globulin Licensed for Use in the United States .............4 Primary or Preexposure Vaccination...................................................................4 Intramuscular Primary Vaccination...............................................................4 Intradermal Primary Vaccination...................................................................4 Preexposure Booster Doses of Vaccine........................................................5 Postexposure Therapy for Previously Vaccinated Persons .......................6 Preexposure Vaccination and Serologic Testing.........................................7 Postexposure Prophylaxis ...................................................................................7 Rationale for Treatment..................................................................................7 Types of Exposure ...................................................................................8 Human-to-Human Transmission ............................................................8 Animal Rabies Epidemiology and Evaluation of Involved Species ..............................................................................9 Circumstances of Biting Incident and Vaccination Status of Exposing Animal............................................11 Treatment of Wounds and Immunization ..................................................11 Treatment of Wounds............................................................................11 Immunization .........................................................................................11 Treatment Outside the United States .........................................................13 Vaccination and Serologic Testing ....................................................................14 Serologic Response Shortly After Vaccination .........................................14 Serologic Response and Preexposure Booster Doses of Vaccine..........14 Adverse Reactions ..............................................................................................15 HDCV, RVA, and PCEC...................................................................................15 Rabies Immune Globulin (Human) .............................................................15 Vaccines and Immune Globulins Used in Other Countries .....................15 Management of Adverse Reactions............................................................16 Precautions and Contraindications ...................................................................16 Immunosuppression.....................................................................................16 Pregnancy.......................................................................................................17 Allergies..........................................................................................................17 References...........................................................................................................17 Insert: Continuing Education Activity ........................................................... CE-1 ii MMWR January 8, 1999 Advisory Committee on Immunization Practices Membership List, October 1998 CHAIRMAN EXECUTIVE SECRETARY John F. Modlin, M.D. Dixie E. Snider, Jr., M.D., M.P.H. Professor of Pediatrics and Medicine Associate Director for Science Dartmouth Medical School Centers for Disease Control Lebanon, New Hampshire and Prevention Atlanta, Georgia MEMBERS Richard D. Clover, M.D. Charles M. Helms, M.D., Ph.D. University of Louisville University of Iowa Hospital and Clinics School of Medicine Iowa City, Iowa Louisville, Kentucky David R. Johnson, M.D., M.H.P. David W. Fleming, M.D. Michigan Department of Oregon Health Division Community Health Portland, Oregon Lansing, Michigan Mary P. Glode, M.D. Chinh T. Le, M.D. The Children’s Hospital Kaiser Permanente Medical Center Denver, Colorado Santa Rosa, California Marie R. Griffin, M.D., M.P.H. Paul A. Offit, M.D. Vanderbilt University Medicial Center The Children’s Hospital of Philadelphia Nashville, Tennesse Philadelphia, Pennsylvania Fernando A. Guerra, M.D. Jessie L. Sherrod, M.D. San Antonio Metropolitan Health District King Drew Medical Center San Antonio, Texas Los Angeles, California Bonnie M. Word, M.D. Monmouth Junction, New Jersey EX OFFICIO MEMBERS Robert F. Breiman, M.D. T. Randolph Graydon Centers for Disease Control Center for Medicaid and and Prevention State Operations Atlanta, Georgia Baltimore, Maryland Geoffrey S. Evans, M.D. M. Carolyn Hardegree, M.D. Health Resources and Food and Drug Administration Services Administration Rockville, Maryland Rockville, Maryland Vol. 48 / No. RR-1 MMWR iii Advisory Committee on Immunization Practices Membership List, October 1998 — Continued Regina Rabinovich, M.D. David H. Trump, M.D., M.P.H. National Institutes of Health Office of the Assistant Secretary Bethesda, Maryland of Defense (Health Affairs) Falls Church, Virginia Kristin Lee Nichol, M.D., M.P.H. VA Medical Center Minneapolis, Minnesota LIAISON REPRESENTATIVES American Academy of Family Physicians Biotechnology Industry Organization Richard Zimmerman, M.D. Yvonne E. McHugh, Ph.D. Pittsburgh, Pennsylvania Emeryville, California American Academy of Pediatrics Canadian National Advisory Larry Pickering, M.D. Committee on Immunization Norfolk, Virginia Victor Marchessault, M.D. Neal A. Halsey, M.D. Cumberland, Ontario Baltimore, Maryland Hospital Infection Control Practices American Association of Health Plans Advisory Committee Gregory P. Gilmet, M.D. Jane D. Siegel, M.D. South Field, Michigan Dallas, Texas American College of Obstetricians Infectious Diseases Society of America and Gynecologists Samuel L. Katz, M.D. Stanley A. Gall, M.D. Durham, North Carolina Louisville, Kentucky National Immunization Council and American College of Physicians Child Health Program, Mexico Pierce Gardner, M.D. Jose Ignacio Santos, M.D. Stony Brook, New York Mexico City, Mexico American Hospital Association National Medical Association William Schaffner, M.D. Walter Faggett, M.D. Nashville, Tennessee Atlanta, Georgia American Medical Association National Vaccine Advisory Committee H. David Wilson, M.D. Georges Peter, M.D. Grand Forks, North Dakota Providence, Rhode Island Association of Teachers of Pharmaceutical Research and Preventive Medicine Manufacturers of America W. Paul McKinney, M.D. Gordon R. Douglas, Jr., M.D. Louisville, Kentucky Whitehouse Station, New Jersey iv MMWR January 8, 1999 Members of the Rabies Working Group Advisory Committee on Immunization Practices (ACIP) ACIP Members Charles M. Helms, M.D., Ph.D., Chairman David W. Fleming, M.D. Marie R. Griffin, M.D., M.P.H. M. Carolyn Hardegree, M.D. John F. Modlin, M.D. National Association of State and Public Health Veterinarians Suzanne Jenkins, V.M.D., M.P.H. Food and Drug Administration Robin Levis, Ph.D. Viral and Rickettsial Zoonoses Branch Division of Viral and Rickettsial Diseases National Center for
Load more

Recommended publications
  • Comparison of Immune Responses Following Intradermal and Intramuscular Rabies Vaccination Methods
    J Med Microbiol Infect Dis, 2018, 6 (4): 77-86 DOI: 10.29252/JoMMID.6.4.77 Review Article Comparison of Immune Responses following Intradermal and Intramuscular Rabies Vaccination Methods Mahsa Golahdooz1, Sana Eybpoosh2, Rouzbeh Bashar1, Mahsa Taherizadeh1, Behzad Pourhossein3, Mohammad Reza Shirzadi4, Behzad Amiri4, Maryam Fazeli1* 1Department of Virology, Pasteur Institute of Iran, Tehran, Iran; 2Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran; 3Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; 4Department of Zoonosis Control, Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran Received Jun. 10, 2018; Accepted Jun. 12, 2019 Rabies is a zoonotic viral disease. The causative agent is a negative-sense RNA genome virus of the genus Lyssavirus (Family: Rhabdoviridae). The disease, commonly transmitted by rabid dogs, is the cause of mortality of over 59000 humans worldwide annually. This disease can be prevented before the development of symptoms through proper vaccination even after exposure. Hence, improvement of the vaccination schedule in the countries where rabies is endemic is essential. In addition to the type of vaccine, injection routes also contribute to enhanced immune responses and increased potency of the vaccines. The vaccines approved by the World Health Organization (WHO) include cell culture and embryonated egg-based rabies vaccines (CCEEVs). In order to develop a vaccine against rabies, it is necessary to use an appropriate delivery system to promote a proper antigen-specific immune response. Different routes of injection such as intradermal (ID), intramuscular (IM) or subcutaneous (SC) are practiced, with controversies over their suitability.
    [Show full text]
  • Update on Rabies
    Research and Reports in Tropical Medicine Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Update on rabies Alan C Jackson Abstract: Human rabies is almost invariably fatal, and globally it remains an important public Departments of Internal Medicine health problem. Our knowledge of rabies pathogenesis has been learned mainly from studies (Neurology) and Medical Microbiology, performed in experimental animal models, and a number of unresolved issues remain. In contrast University of Manitoba, Winnipeg, with the neural pathway of spread, there is still no credible evidence that hematogenous spread MB, Canada of rabies virus to the central nervous system plays a significant role in rabies pathogenesis. Although neuronal dysfunction has been thought to explain the neurological disease in rabies, recent evidence indicates that structural changes involving neuronal processes may explain the severe clinical disease and fatal outcome. Endemic dog rabies results in an ongoing risk to humans in many resource-limited and resource-poor countries, whereas rabies in wildlife is For personal use only. important in North America and Europe. In human cases in North America, transmission from bats is most common, but there is usually no history of a bat bite and there may be no history of contact with bats. Physicians may not recognize typical features of rabies in North America and Europe. Laboratory diagnostic evaluation for rabies includes rabies serology plus skin biopsy, cerebrospinal fluid, and saliva specimens for rabies virus antigen and/or RNA detection. Methods of postexposure rabies prophylaxis, including wound cleansing and administration of rabies vaccine and human rabies immune globulin, are highly effective after recognized exposure.
    [Show full text]
  • Fact Sheet: Rabies in Louisiana
    Infectious Disease Epidemiology Section Office of Public Health, Louisiana Dept of Health & Hospitals 800-256-2748 (24 hr number) – (504) 219-4563 www.oph.dhh.state.la.us Dr. Gary A. Balsamo State Public Health Veterinarian Fact Sheet: Rabies in Louisiana Although rabies remains endemic in wildlife in Louisiana, especially bats and skunks, the disease in pet species, particularly dogs, has been decreasing in occurrence since the early 1900s. This decrease is likely due to rabies vaccination programs and organized animal control activities. Human rabies has not been seen in Louisiana since 1953. Since 1996 an average of 7.9 cases of animal rabies has been discovered each year in the state. No positive dogs or cats have been identified since the year 2000. The shift in the risk of rabies transmission from domestic dogs to wildlife has occurred throughout all areas of the United States. Due to increased surveillance for wildlife rabies, the number of reported cases has increased in the past few decades. Rabies is considered a disease of all warm-blooded animals, but the virus circulates in nature in only a few species, such as bats, raccoons, foxes, skunks, and coyotes. The only terrestrial rabies variant known to occur within Louisiana is a skunk variant, although discovery of raccoon variant rabies is also possible. Bat variants of the virus also are found in the state. Although a limited number of species maintain the virus in nature, all warm blooded animals are susceptible to infection. Therefore public health concerns include human exposure to animals other than those responsible for maintenance of variants.
    [Show full text]
  • Rabies Surveillance and Investigation Report, 2018
    Rabies Surveillance and Investigation Report, 2018 In 2018, a total of 261 animal specimens were submitted to the District of Columbia Department of Health (DC Health) for rabies testing (Figure 1). The District of Columbia Public Health Laboratory (DC PHL) tested the specimens using the Direct Fluorescent Antibody (DFA) test, the current gold standard test for rabies1. Rabies Testing in Wild and Domestic Animals in DC 100 90 80 70 60 Specimen Unsatisfactory for Testing 50 Positive 40 30 Negative Number of animals tested animals of Number 20 10 0 Bat Cat Dog Other Raccoon Species Figure 1. Wild and Domestic Animals tested for Rabies in DC, 2018. The major rabies variants in the eastern United States (US) occur among raccoons, skunks, red and gray foxes, coyotes, and multiple insectivorous bat species. The raccoon rabies variant (RRV) is enzootic in eastern US including the District of Columbia (DC)2. Approximately 8.8% (23 out of 261) of samples submitted tested positive for the rabies virus. This was similar to findings in 2017 when less than 12% of samples submitted tested positive for rabies. The most commonly tested animal species were dogs (n=94), followed by bats (n=64), and raccoons (n=51). Raccoons most commonly tested positive, with 41.2% (n=21/51) of submitted raccoon samples being positive for rabies. This showed a decrease compared to 2017 when 52.6% of submitted raccoons tested positive. However, the percentage of rabid raccoons among all animal specimens submitted for testing (19.5%, n=21/261) showed an increase from the previous year (10.2%, n=20/196).
    [Show full text]
  • Frequently Asked Questions About Rabies for the General Public
    Frequently asked questions about rabies for the General Public 1 Version 2018 SECTION I. TABLE OF CONTENTS RABIES OVERVIEW 3 Q.1 WHAT IS RABIES? 3 Q.2 WHERE DOES RABIES OCCUR? 3 PREVENTION OF RABIES FOLLOWING A BITE 4 Q.3 WHAT IS POST-EXPOSURE PROPHYALXIS (PEP)? 4 Q.4 DO YOU HAVE TO RECEIVE VACCINATION AGAINST RABIES IF A DOG OF UNKNOWN VACCINE STATUS BITES YOU? 4 Q.5 DO YOU HAVE TO GET A VACCINATION AGAINST RABIES IF A VACCINATED DOG BITES YOU? 4 Q.6 HOW SHOULD AN ANIMAL BITE BE TREATED? 4 Q.7 IS SIMPLY OBSERVING THE BITING ANIMAL FOR 10 DAYS WITHOUT STARTING PEP JUSTIFIED? 5 PREVENTION OF RABIES BEFORE A BITE 5 Q.8 WHAT CAN BE DONE TO PREVENT AND CONTROL RABIES? 5 Q.9 HOW CAN WE PREVENT DOGS FROM BITING 6 Q.10 WHAT IS PRE-EXPOSURE PROPHYLAXIS (PREP)? 6 Q.11 IS THERE A SINGLE-DOSE HUMAN RABIES VACCINE THAT WILL PROVIDE LIFE-LONG IMMUNITY? 7 RABIES TRANSMISSION FROM ANIMALS 7 Q.12 HOW IS RABIES TRANSMITTED? 7 Q.13 THROUGH WHAT BODILY PRODUCTS CAN RABIES BE TRANSMITTED? 7 Q.14 CAN THE CONSUMPTION OF RAW MEAT FROM A RABIES-INFECTED ANIMAL TRANSMIT RABIES? 7 Q.15 IS PEP NECESSARY IF MILK OR MILK PRODUCTS FROM A RABIES-INFECTED ANIMAL ARE CONSUMED? 8 Q.16 WHAT SHOULD I DO IF MYSELF OR MY PET HAS HAD CONTACT WITH A BAT? 8 Q.17 DO YOU REQUIRE PEP IF BITTEN BY A RAT? 9 RABIES TRANSMISSION FROM HUMANS 9 Q.18 THROUGH WHAT BODILY PRODUCTS CAN RABIES BE TRANSMITTED? 9 Q.19 CAN RABIES BE TRANSMITTED THROUGH ORGAN TRANSPLANTATION? 9 RABIES SYMPTOMS 9 Q.20 WHAT ARE THE SYMPTOMS OF RABIES IN A DOG? 9 Q.21 HOW DOES RABIES DEVELOP IN HUMANS? 10 Q.22 WHAT ARE THE SYMPTOMS OF RABIES IN HUMANS? 10 Q.23 WHAT FACTORS INFLUENCE THE DEVELOPMENT OF HUMAN RABIES? 10 Q.24 IS RABIES ALWAYS FATAL? 11 Q.25 IS THERE ANY SPECIFIC TREATMENT FOR A RABIES PATIENT? 11 RABIES VACCINE SAFETY 12 2 Q.26 IS IT POSSIBLE TO DEVELOP RABIES FROM THE VACCINATION? 12 Q.27 IS RABIES VACCINATION DURING PREGNANCY AND LACTATION SAFE? 12 RABIES OVERVIEW Q.1 WHAT IS RABIES? Rabies is a viral disease transmitted from mammals to humans that causes an acute encephalitis.
    [Show full text]
  • Manual for Rabies Control and Animal Bite Management
    MANUAL FOR RABIES CONTROL AND ANIMAL BITE MANAGEMENT 2020 Manual for Rabies Control and Bite Management Table of Contents Objectives and Introduction……………………………………………………………………………………………2 Definitions…………………………………………………………………………………………………………………….3 Rabies Biology……………………………………………………………………………………………………………….4 Epidemiology of Rabies…………………………………………………………………………………………………..5 Rabies in Animals…………………………………………………………………………………………………………..7 Quarantine and Observation of Animals…………………………………………………………………………..12 Rabies in Wildlife…………………………………………………………………………………………………………..16 Human Rabies Immunoglobulin, Pre-exposure and Post-Exposure Prophylaxis..………………….19 Algorithms……………………………………………………………………………………………………………………25 Management of Rabies-Related Human Exposures……………………………………………………………29 Humane Euthanasia of Animals……………………………………………………………………………………….31 Guidelines for the Submission of Specimens for Rabies Testing………………………………………….32 Appendix……………………………………………………………………………………………………………………..35 1 Objectives This manual provides guidance to public health, veterinarians, animal control officers, wildlife biologists, wildlife rehabilitators, and other agencies regarding rabies surveillance and control, as well as best practices for animal bite management in Arizona. These recommendations are based on the Compendium of Animal Rabies Prevention and Control, 2016, the Advisory Committee on Immunization Practices Guidelines, 2010, Arizona’s laws (Arizona Revised Statues - Article 6 sections 11-1001 through 11-1027, and the Arizona Administrative Code - Communicable Disease Rules
    [Show full text]
  • Animal Bites and Rabies Risk Manual
    ANIMAL BITES RABIES RISK a guide for health professionals For Consultation on Animal Bites and Rabies Risk in Humans Minnesota Department of Health Zoonotic Diseases Unit 625 North Robert Street St. Paul, MN 55155 Telephone: 651-201-5414 or toll free: 1-877-676-5414 • 24/7 telephone consultation on potential rabies exposure is available to healthcare providers, veterinarians, public health professionals, and law enforcement. • Rabies consultations are available to the public Monday through Friday, 8:30 a.m. to 4:30 p.m. For Consultation on Rabies Exposure of Animals Minnesota Board of Animal Health 625 North Robert Street St. Paul, MN 55155 Telephone: 651-201-6808 For Specimen Submission Specimens from suspect rabies animals should be delivered to: Business hours (Monday - Friday, 8:00 a.m. to 4:30 p.m.) Minnesota Veterinary Diagnostic Laboratory University of Minnesota-St. Paul Campus 1333 Gortner Avenue St. Paul, MN 55108 Phone: 612-625-8787 - 2 - ANIMAL BITES AND RABIES RISK: A GUIDE FOR HEALTH PROFESSIONALS Table of Contents I. INTRODUCTION ............................................................................................................ 5 II. MANAGEMENT OF ANIMAL BITES TO HUMANS ......................................................... 5 Consultations on animal bites and rabies risk ........................................................................5 Evaluation of the patient following an animal bite ...............................................................5 Assessment of the need for rabies post-exposure prophylaxis
    [Show full text]
  • Public Veterinary Medicine: Public Health Rabies Surveillance in the United States During 2001
    2002pvmkrebs.qxd 12/4/2002 2:11 PM Page 1690 Public Veterinary Medicine: Public Health Rabies surveillance in the United States during 2001 John W. Krebs, MS; Heather R. Noll, MPH; Charles E. Rupprecht, VMD, PhD; James E. Childs, ScD Summary: During 2001, 49 states and Puerto Rico reported abies in the United States and other developed 7,437 cases of rabies in nonhuman animals and 1 case in a nations is primarily a disease that affects and is human being to the Centers for Disease Control and R Prevention, an increase of < 1% from 7,364 cases in nonhu- maintained by wildlife populations (Fig 1). During man animals and 5 human cases reported in 2000. More than 2001, wild animals accounted for more than 93% of all 93% (6,939 cases) were in wild animals, whereas 6.7% (497 cases of rabies reported to the Centers for Disease cases) were in domestic species (compared with 93.0% in Control and Prevention (CDC). Although the wildlife wild animals and 6.9% in domestic species in 2000). The number of cases reported in 2001 increased among bats, species most frequently reported rabid remain rac- cats, skunks, rodents/lagomorphs, and swine and decreased coons, skunks, bats, and foxes, the relative contribu- among dogs, cattle, foxes, horses/mules, raccoons, and tions of those species have continued to change in sheep/goats. The relative contributions of the major groups recent decades (Fig 2) because of fluctuations in epi- of animals were as follows: raccoons (37.2%; 2,767 cases), zootics of rabies among animals infected with several skunks (30.7%; 2,282), bats (17.2%; 1,281), foxes (5.9%; 1 437), cats (3.6%; 270), dogs (1.2%; 89), and cattle (1.1%; distinct variants of the rabies virus.
    [Show full text]
  • Rabies and the ACO Rabies Rabies Transmission Rabies Transmission
    www.wendyblount.com Rabies and the ACO Wendy Blount, DVM Rabies Rabies Transmission • Infectious agent : virus that attacks • Hosts: nervous system – All warm-blooded animals are susceptible – Causes brains cells to malfunction • Reptiles and birds don ’t get rabies – Worldwide - tens of thousands of human – Young animals are more susceptible than deaths yearly adults – 0-5 deaths per year in the US – Least susceptible to disease (rare): – Death by lightening strike is more likely • Marsupials – opossums (curriculum says no) – Fear of disease such as rabies was a major contributing factor to the – Domestic animals most likely to be diagnosed development of animal control which with rabies in the US: began in the late 1800 ’s in the US • Cat > Dog > Cow > Horse/mule > sheep/goat Rabies Transmission Rabies Transmission • Hosts: • Hosts: – Cats are more likely to have rabies than – Those to which the virus has an adapted subtype dogs in the US transmit the virus best – These are called “high risk ” animals and are • Most of these spill over from raccoon rabies on “reservoir species ” the East Coast • Dog (wild or domestic – fox,fox coyote,coyote wolf,wolf etc.) • Fewer cats than dogs are vaccinated for rabies • Raccoon, Skunk,Skunk Mongoose • There are fewer leash laws for cats than for • Cow (South America only) dogs • Bat (vampire, insectivorous, not vegetarian) – Cats, bobcats and cougars can also be vectors • Vector – animal that actively or passively transmits a disease 1 Rabies Transmission Rabies Surveillance • Hosts: • Hosts: Terrestrial
    [Show full text]
  • Rabies Epidemiology, Prevention and Control
    RABIES EPIDEMIOLOGY, PREVENTION AND CONTROL John R. Dunn, DVM, PhD Deputy State Epidemiologist State Public Health Veterinarian https://tn.gov/assets/entities/health/attachments/RabiesManual2016.pdf Rabies virus v RNA virus • Host-adapted variants • Enveloped virus—rapidly destroyed in environment v Neurotropic • Long, highly variable incubation period • Causes rapidly progressive, fatal encephalitis v No “carrier” state Worldwide burden of illness • Kills ~60,000 annually, Asia and Africa • Vaccine-preventable • Sustained elimination of dog-to-dog transmission has been demonstrated Human rabies epidemiology: US v 2-3 cases per year §Bat variants in locally-acquired cases §Canine variant in immigrants / travelers • Last Tennessee case in 2002 (bat) • Last case in Tennessee due to a rabid dog bite was 1955 United States: Bat-variant rabies § Majority of human rabies • ~ 75% cases • Silver-haired/Eastern pipistrelle bat § Minor bite wound, difficult to detect Human rabies clinical presentation • Incubation • Highly variable (1 week to >1 year), averages 30-90 days • Nonspecific prodrome • Up to 10 days • Fever, headache, nausea, paresthesia at site of bite • Progressive neurologic phase • 2-10 days • Confusion, agitation, hypersalivation, hydrophobia, aerophobia, dysphagia • Paralysis, coma: hours to days • Death: mortality almost 100% once symptoms develop 2002 Tennessee Case • 13 year old Franklin County boy • Brought home bat he found on the ground ~ July 1, not reported, no bite noted • Onset August 21 (7 week incubation) • Headache,
    [Show full text]
  • Rabies Surveillance and Prevention Recommendations for Providers Alicia Lepp Epidemiologist Division of Disease Control North Dakota Department of Health
    Rabies Surveillance and Prevention Recommendations for Providers Alicia Lepp Epidemiologist Division of Disease Control North Dakota Department of Health Michelle Feist Epidemiology and Surveillance Program Manager Division of Disease Control North Dakota Department of Health Rabies ‐ Background • Lyssavirus belonging to the Rhabdoviridae family – “bullet‐shaped virus” – RNA virus • Rabies is a virus that affects the central nervous system in mammals – Virus travels within the nerves – Within the brain, virus multiplies rapidly • Signs of disease begin to develop Rabies ‐ Background • More than 90 percent of rabies cases reported each year in the United States occur in wildlife – 36.5% raccoons – 23.5% skunks – 23.2% bats – 7% foxes – 1.8% other species • Raccoons and skunks are responsible for most reported animal cases in the United States – In ND – skunks • Different variants (bat, skunk, raccoon, etc.) Terrestrial Rabies Reservoirs(2010) http://www.cdc.gov/rabies/location/usa/surveillance/wild_animals.html Rabid Cats and Dogs Reported in the U.S. (2010) http://www.cdc.gov/rabies/resources/publications/2010‐surveillance/cats‐and‐dogs.html Rabies in North Dakota • ~ 350 to 450 animals tested per year – 729 animals tested in 2012 • ~ 30 positive rabies animals per year – 8% positive Rabies in North Dakota • Positive Animals Rabies Cases by County, North Dakota, 2012 Positive Rabies in Domestic and Wild Animals Human Rabies Around the World • Rabies is a global health issue • Human cases are underreported – Most rabies cases occur in countries with inadequate diagnostic facilities and surveillance systems for rabies • Exposure to rabid dogs is the cause of over 90% of human exposures and over 99% of human rabies deaths1 • Limited access to healthcare and resources 1‐ http://www.cdc.gov/rabies/location/world/index.html Rabies in the U.S.
    [Show full text]
  • Comparison of Immune Responses Following Intradermal and Intramuscular Rabies Vaccination Methods
    J Med Microbiol Infect Dis, 2018, 6 (4): 77-86 DOI: 10.29252/JoMMID.6.4.77 Archive of SID Review Article Comparison of Immune Responses following Intradermal and Intramuscular Rabies Vaccination Methods Mahsa Golahdooz1, Sana Eybpoosh2, Rouzbeh Bashar1, Mahsa Taherizadeh1, Behzad Pourhossein3, Mohammad Reza Shirzadi4, Behzad Amiri4, Maryam Fazeli1* 1Department of Virology, Pasteur Institute of Iran, Tehran, Iran; 2Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran; 3Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; 4Department of Zoonosis Control, Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran Received Jun. 10, 2018; Accepted Jun. 12, 2019 Rabies is a zoonotic viral disease. The causative agent is a negative-sense RNA genome virus of the genus Lyssavirus (Family: Rhabdoviridae). The disease, commonly transmitted by rabid dogs, is the cause of mortality of over 59000 humans worldwide annually. This disease can be prevented before the development of symptoms through proper vaccination even after exposure. Hence, improvement of the vaccination schedule in the countries where rabies is endemic is essential. In addition to the type of vaccine, injection routes also contribute to enhanced immune responses and increased potency of the vaccines. The vaccines approved by the World Health Organization (WHO) include cell culture and embryonated egg-based rabies vaccines (CCEEVs). In order to develop a vaccine against rabies, it is necessary to use an appropriate delivery system to promote a proper antigen-specific immune response. Different routes of injection such as intradermal (ID), intramuscular (IM) or subcutaneous (SC) are practiced, with controversies over their suitability.
    [Show full text]